TIS 0.00% 0.0¢ tissue therapies limited

another positioning, page-13

  1. 2,203 Posts.
    lightbulb Created with Sketch. 72
    resourced,

    I am sure we are footing the bill for the Boston conference, just as I am sure that this has all been part of the plan to advertise and promote VitroGro for the markets around the world!

    Just think of what they are achieving by going straight to the movers and shakers of the industry!

    Prof Upton is the lead person for VitoGro,

    Prof Upton was and still is the main developer of the CRC wound centre.

    Dr Mercer is really focused on the launch and development of VitroGro.

    Prof Keith Harding is really jealous of the CRC wound development program in Australia as he has been trying to get one started in Europe for some time.

    I am sure that if the approval comes while they are at the Boston conference we will know about it promptly and that the firing gun will be started to get all the machinery under way for the launch.

    Here's to an interesting few weeks (and years) ahead.

    Regards..................
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.